# FDA Inspection 611821 - Merck & Co., Inc. - September 22, 2009

Source: https://www.globalkeysolutions.net/records/fda_inspections/merck-co-inc/cdb041d3-40e3-4c87-8d45-5e44e1fa0851
Source feed: FDA_Inspections

> FDA Inspection 611821 for Merck & Co., Inc. on September 22, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 611821
- Company Name: Merck & Co., Inc.
- Inspection Date: 2009-09-22
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 777397 - 2012-04-20](https://www.globalkeysolutions.net/records/fda_inspections/merck-co-inc/f11701d3-da0c-4753-8b2d-64505795c7f2)
- [FDA Inspection 608411 - 2009-08-31](https://www.globalkeysolutions.net/records/fda_inspections/merck-co-inc/db1ef8eb-baf9-4512-a62a-11432805c748)

Company: https://www.globalkeysolutions.net/companies/merck-co-inc/32420cc6-9aa6-42f9-b150-80a0bc7b29a5

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c